Stereotaxis Inc. announced that Gery Tomassoni M.D. FHRS has been appointed as Chief Medical Officer (CMO), effective immediately for a three-year term. Dr. Tomassoni is Director of Electrophysiology at Central Baptist Hospital in Lexington, KY. In this capacity, Dr. Tomassoni will serve as the company's clinical leader for scientific, product, clinical training and applications development.

He will continue his practice in Lexington, KY and consult in his new role on a part time basis. As an early adopter in February 2003, Dr. Tomassoni has been a long-term user of Stereotaxis technology in the treatment of complex arrhythmia. He and his team of electrophysiologists at Central Baptist Hospital were the first in the US to complete a case using the combination of Stereotaxis robotic technology with 3-D mapping technology.

Dr. David Burkhardt who served as the CMO for the past three years has agreed to continue his relationship in the role of Chief Development Advisor. In this capacity, Dr. Burkhardt will continue working along with Dr. Tomassoni with new product development teams focused on advancing the Epoch(TM) Solution robotic navigation technology platform.